Educational tool only · Not medical advice · Always use your clinical judgment · Verify all information independently

This brief is 100% free to read. No login required.

Evidence verified against 2024-2025 systematic reviews

Pediatric NeuroModerate evidencePilot Study 2026 High-Standard

Activity-Based Locomotor Training with Spinal Stimulation: A New Frontier for Pediatric SCI

This brief explores a recent pilot study combining activity-based locomotor training (AB-LT) with non-invasive transcutaneous spinal cord stimulation (scTS) for children with spinal cord injury (SCI). The findings suggest this combination is safe and can lead to significant improvements in trunk control, offering a promising new therapeutic avenue for this population.

Research: June 2025

Related Videos

Physical Therapy: Early Intervention for Cerebral Palsy

Pediatric Physical Therapy for a Child with Cerebral Palsy

Key Findings

  • 1Combining activity-based locomotor training (AB-LT) with transcutaneous spinal cord stimulation (scTS) is safe and feasible for children with spinal cord injury.
  • 2The combined intervention led to improved trunk control in all participants, both in quiet sitting and during balance challenges.
  • 3Increased muscle activation was observed in the trunk, even below the level of the spinal cord injury.
  • 4The majority of intervention sessions (88.5%) were completed without any adverse effects.
  • 5This pilot study provides initial evidence for the synergistic benefits of combining AB-LT and scTS in pediatric SCI rehabilitation.
We're constantly on the lookout for new ways to help our pediatric patients with spinal cord injury (SCI) not just adapt, but truly recover. That's why we were so interested in a recent pilot study that explored the combination of two powerful modalities: activity-based locomotor training (AB-LT) and non-invasive transcutaneous spinal cord stimulation (scTS). This study, while small, offers a glimpse into a future where we can potentially enhance neuroplasticity and achieve greater functional gains for these kids. For years, we've known that the developing nervous system of a child with SCI is a double-edged sword. On one hand, their immaturity puts them at a high risk for secondary complications like scoliosis. On the other, it also presents a unique window of opportunity for recovery. Activity-based therapies, like the locomotor training we do in the clinic, are designed to tap into this potential by providing the central nervous system with the sensory input it needs to relearn motor tasks. We've seen firsthand how AB-LT can improve trunk control, which is so foundational for everything from sitting balance to walking. This pilot study took things a step further by adding scTS to the mix. The idea here is that by delivering a low-level electrical current to the spinal cord, we can essentially “prime” the neural circuits involved in movement, making them more receptive to the effects of the locomotor training. The study included three boys with chronic SCI who had already completed at least 60 sessions of AB-LT. They then underwent an additional 19 to 64 sessions of AB-LT, this time with the addition of scTS. The intervention itself was quite comprehensive. Each session involved a period of sitting with scTS to optimize the stimulation parameters, followed by locomotor training on a treadmill and overground. The treadmill training involved partial body weight support and manual facilitation from therapists to promote proper stepping kinematics. The overground training challenged the participants' trunk control in a variety of sitting, standing, and stepping activities. The scTS was applied using electrodes placed on the skin over the thoracic and lumbar spine, with a 10 kHz current delivered in short bursts. The results were really encouraging. All three participants showed measurable improvements in trunk control, both in quiet sitting and when their balance was challenged. They were better able to maintain an upright posture and showed increased muscle activation in their trunk, even below the level of their injury. This suggests that the combination of AB-LT and scTS was indeed promoting neural remodeling and enhancing the neuromuscular capacity for trunk control. Of course, with any new intervention, safety is a top concern. The researchers in this study were very diligent about monitoring for adverse effects. While there were a few instances of autonomic dysreflexia, skin redness, and headaches, the vast majority of the sessions (88.5%) were completed without any issues. This is a crucial finding, as it suggests that with careful monitoring, this combined therapy can be safely implemented in a clinical setting. So, what does this all mean for us as clinicians? This pilot study provides the first piece of evidence that combining AB-LT with scTS is not only safe and feasible for children with SCI, but also has the potential to be more effective than AB-LT alone. It's a promising step forward in our quest to maximize recovery for these young patients. While we need larger, controlled studies to confirm these findings and optimize the treatment protocols, this research gives us a solid foundation to build upon. It's an exciting time to be in the field of pediatric neurorehabilitation, and we're eager to see how this innovative approach will continue to evolve and benefit the children we serve.

Clinician's Note

As a clinician, I'm incredibly excited by the possibilities that this research opens up. For so long, we've been working to help children with SCI compensate for their injuries. This study, however, points towards a future where we can focus more on restoration and recovery. The idea that we can use a non-invasive technology like scTS to amplify the effects of our existing therapies is a game-changer. It's a reminder that our field is constantly evolving, and that we must remain open to new ideas and innovations that can improve the lives of our patients.

Clinic Action Plan

[ "Educate our clinical team on the principles and potential benefits of combining AB-LT with scTS.", "Develop a protocol for implementing this combined therapy, including patient selection criteria, safety monitoring procedures, and outcome measures.", "Invest in the necessary equipment and training to safely and effectively deliver scTS.", "Start a pilot program with a small number of appropriate patients to gain clinical experience and gather data.", "Collaborate with researchers and other clinicians to stay up-to-date on the latest evidence and best practices in this emerging area.", "Disseminate our findings and experiences to the wider pediatric neurorehabilitation community." ]

Common Mistakes to Avoid

  • Assuming that scTS is a standalone treatment rather than an adjunct to activity-based therapy.
  • Failing to properly monitor for and manage potential adverse effects like autonomic dysreflexia and skin irritation.
  • Not optimizing the scTS parameters for each individual patient.
  • Expecting immediate and dramatic results, rather than understanding that this is a long-term process of neural remodeling.
  • Neglecting the importance of a comprehensive, multi-disciplinary approach to pediatric SCI rehabilitation.

Frequently Asked Questions

Premium Deep Dive

This brief includes an extended deep-dive section with clinical nuance, dosing details, edge cases, and special population considerations.

Unlock with Premium — $99/yr

Meets 2026 NeuroDash High-Standard Criteria

This brief passes all 6 mandatory quality criteria: objective outcome measures, 5+ DOI-linked sources from top-tier institutions, GRADE evidence rating, specific dosing parameters, 3+ recent (2023–2026) citations, and a step-by-step Clinic Action Plan.

Last verified April 21, 2026 Based on 2023–2026 systematic reviews All outcome measures are quantifiable
View the 2026 Research Quality Master Criteria
GRADE-graded with DOI links Evidence verified
This brief is for educational purposes only. Always verify clinical decisions with peer-reviewed sources and your professional judgment.

Want more from NeuroDash?

Save protocols, track CEU hours, download PDFs, and get unlimited AI access.

Explore Premium — $99/yr